Why Is GALT Trading Higher Today?

Why Is GALT Trading Higher Today?

Galectin Therapeutics ($GALT@US) shares are up this morning after the firm announced excellent results from its Phase 1b clinical study of Belapectin with Keytruda. They conduct research with the hopes of aiding individuals suffering from metastatic melanoma and head and neck cancer. Their stock is listed on the NASDAQ, and as of press time, shares were up 40.94.


User: Benzinga

Views: 0

Uploaded: 2021-09-01

Duration: 00:26

Your Page Title